Trial reportPhysiological reports2026
Assessing head injury risk and neuroprotective effect of ketone monoester supplementation in military airborne training.
Trial report in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Warfighters face significant risk of mild traumatic brain injury (mTBI) during operations and training. We performed a double-blind, randomized, placebo-controlled trial to: (1) determine head strike (HS) incidence, during US Army Basic Airborne Course's Improved Swing Landing Trainer (ISLT) training, (2) test protective efficacy of ketone monoester (KME) supplementation, and (3) assess blood-based mTBI biomarker signatures. We enrolled 354 active-duty male and female service members randomized 1:1 to placebo (PLA) or KME; n = 318 completed ISLT and assessments (PLA = 157, 142 M/15F; KME = 161, 144 M/18F). N = 112 (35.2%; 35.7% in PLA, 34.8% in KME) experienced HS, defined as whiplash or helmet-to-ground impact. Assessments included the Automated Neuropsychological Assessment Metric (ANAM-4), SWAY balance testing, and plasma biomarkers. One ANAM-4 measure (Simple Reaction Time-Repeat; p = 0.024) and one SWAY measure (Single Leg Right; p = 0.014) demonstrated significant HS × Time × Treatment interactions, with performance decrements in HS + PLA not observed in HS + KME. Several HS × Time interactions were observed for ANAM-4 and SWAY variables, indicating HS-induced cognitive and balance decline. No relevant blood-based biomarker patterns were associated with HS or KME. Predictive modeling identified variables associated with HS risk with moderate accuracy. In conclusion, ISLT resulted in ~32% head injury incidence and KME supplementation showed limited protection of cognitive and balance without corresponding biomarker changes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.